Pfizer Applies for FDA Approval for Coronavirus Vaccine for Children

Pfizer Applies for FDA Approval for Coronavirus Vaccine for Children


Pfizer announced Thursday it applied to the Food and Drug Administration (FDA) for approval of its vaccine for 5-11-year-olds — a significant move, as no coronavirus vaccine has been approved for children younger than 12.

The FDA advisory committee is expected to discuss Pfizer’s application on October 26.

The application comes on the heels of Pfizer’s announcement last month, reporting its vaccine to be effective for kids in the younger age bracket:

For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill

Trending: DEVELOPING: Five People and One Police Officer Injured in Boise, Idaho Mall Shooting – One Suspect in Custody (VIDEO)

Continue reading

You Might Like

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend